Table 1.
Mechanism of action and GI50 values of agents used
| Cmpd | Mechanism of Action | U2OS GI50 (μM) | Ref | |
|---|---|---|---|---|
|
| ||||
| Mean | SD | |||
| V158411 | Chk1 Inhibitor | 0.82 | 0.1 | [11] |
| VX-970 | ATR Inhibitor | 3.5 | 0.77 | [50] |
| AZD1775 | Wee1 Inhibitor | 0.27 | 0.036 | [51] |
| Gemcitabine | Chain terminator & RNR inhibitor | 0.012 | 0.001 | |
| Camptothecin | Topo I inhibitor | 0.25 | 0.003 | |
| Etoposide | Topo II inhibitor | 4.2 | 0.32 | |
| LY2603618 | Chk1 inhibitor | 0.67 | 0.05 | [52] |
| MK8776 | Chk1 inhibitor | 0.82 | 0.05 | [53] |
| PF-477736 | Chk1 inhibitor | 0.71 | 0.06 | [54] |
| Cisplatin | DNA alkylator | 7.5 | 0.77 | |
| Hydroxyurea | RNR inhibitor | 2800 | 1100 | |
| KU-60019 | ATM inhibitor | 24 | 9.2 | [55] |
| NU7746 | DNA-PKcs inhibitor | 8.6 | 0.48 | [56] |